Genetic testing in screening patients with lung cancer that has been or will be removed by surgery.
Studying the genes in a patient's tumor cells may help determine the best treatment for patients that have certain genetic changes.
Large Cell Lung CarcinomaLung AdenocarcinomaStage IB Non-Small Cell Lung Carcinoma AJCC v7Stage IB Squamous Cell Lung Carcinoma AJCC v7Stage II Non-Small Cell Lung Cancer AJCC v7Stage II Squamous Cell Lung Carcinoma AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIA Squamous Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Squamous Cell Lung Carcinoma AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7Stage IIIA Squamous Cell Lung Carcinoma AJCC v7CarcinomaLung NeoplasmsCarcinoma, Non-Small-Cell LungAdenocarcinomaAdenocarcinoma of LungNivolumabErlotinib HydrochlorideCrizotinibClinical ObservationCytology Specimen Collection Procedure
Lead Scientist at UC Health
- Lyudmila A. Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- accepting new patients
- Start Date
- National Cancer Institute (NCI)
- Phase 3
- Study Type
- Last Updated